Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement.

Carey CE, Agrawal A, Bucholz KK, Hartz SM, Lynskey MT, Nelson EC, Bierut LJ, Bogdan R.

Front Genet. 2016 Aug 15;7:149. doi: 10.3389/fgene.2016.00149. eCollection 2016 Aug 15.

2.

Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus.

Suryavanshi PS, Gupta SC, Yadav R, Kesherwani V, Liu J, Dravid SM.

Mol Pharmacol. 2016 Aug;90(2):96-105. doi: 10.1124/mol.116.104786.

PMID:
27231330
3.

Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic Variants.

Bagley SC, Sirota M, Chen R, Butte AJ, Altman RB.

PLoS Comput Biol. 2016 Apr 26;12(4):e1004885. doi: 10.1371/journal.pcbi.1004885.

4.

Childhood Household Dysfunction, Social Inequality and Alcohol Related Illness in Young Adulthood. A Swedish National Cohort Study.

Gauffin K, Hjern A, Vinnerljung B, Björkenstam E.

PLoS One. 2016 Mar 18;11(3):e0151755. doi: 10.1371/journal.pone.0151755.

5.

The Genetic Architecture of Murine Glutathione Transferases.

Lu L, Pandey AK, Houseal MT, Mulligan MK.

PLoS One. 2016 Feb 1;11(2):e0148230. doi: 10.1371/journal.pone.0148230.

7.

Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition.

Rivero O, Selten MM, Sich S, Popp S, Bacmeister L, Amendola E, Negwer M, Schubert D, Proft F, Kiser D, Schmitt AG, Gross C, Kolk SM, Strekalova T, van den Hove D, Resink TJ, Nadif Kasri N, Lesch KP.

Transl Psychiatry. 2015 Oct 13;5:e655. doi: 10.1038/tp.2015.152.

8.

Shared additive genetic influences on DSM-IV criteria for alcohol dependence in subjects of European ancestry.

Palmer RH, McGeary JE, Heath AC, Keller MC, Brick LA, Knopik VS.

Addiction. 2015 Dec;110(12):1922-31. doi: 10.1111/add.13070.

9.

CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis.

Cho CH, Lee HJ, Woo HG, Choi JH, Greenwood TA, Kelsoe JR.

Psychiatry Investig. 2015 Jul;12(3):402-7. doi: 10.4306/pi.2015.12.3.402.

10.

Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations.

Yarosh HL, Meda SA, de Wit H, Hart AB, Pearlson GD.

Psychopharmacology (Berl). 2015 Aug;232(15):2781-94. doi: 10.1007/s00213-015-3914-1.

11.

Quantitative trait locus mapping of acute functional tolerance in the LXS recombinant inbred strains.

Bennett B, Larson C, Richmond PA, Odell AT, Saba LM, Tabakoff B, Dowell R, Radcliffe RA.

Alcohol Clin Exp Res. 2015 Apr;39(4):611-20. doi: 10.1111/acer.12678.

12.

The guanine nucleotide exchange factor (GEF) Asef2 promotes dendritic spine formation via Rac activation and spinophilin-dependent targeting.

Evans JC, Robinson CM, Shi M, Webb DJ.

J Biol Chem. 2015 Apr 17;290(16):10295-308. doi: 10.1074/jbc.M114.605543.

13.

Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.

Gupta SC, Yadav R, Pavuluri R, Morley BJ, Stairs DJ, Dravid SM.

Neuropharmacology. 2015 Jun;93:274-84. doi: 10.1016/j.neuropharm.2015.02.013.

14.

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.

Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA Jr.

J Psychopharmacol. 2015 May;29(5):596-607. doi: 10.1177/0269881114568041.

15.
16.

Genetic background of extreme violent behavior.

Tiihonen J, Rautiainen MR, Ollila HM, Repo-Tiihonen E, Virkkunen M, Palotie A, Pietiläinen O, Kristiansson K, Joukamaa M, Lauerma H, Saarela J, Tyni S, Vartiainen H, Paananen J, Goldman D, Paunio T.

Mol Psychiatry. 2015 Jun;20(6):786-92. doi: 10.1038/mp.2014.130.

17.

Genome-wide association discoveries of alcohol dependence.

Zuo L, Lu L, Tan Y, Pan X, Cai Y, Wang X, Hong J, Zhong C, Wang F, Zhang XY, Vanderlinden LA, Tabakoff B, Luo X.

Am J Addict. 2014 Nov-Dec;23(6):526-39. doi: 10.1111/j.1521-0391.2014.12147.x. Review.

18.

Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.

Sharp SI, McQuillin A, Marks M, Hunt SP, Stanford SC, Lydall GJ, Morgan MY, Asherson P, Curtis D, Gurling HM.

Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):373-80. doi: 10.1002/ajmg.b.32241.

19.

Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.

Nord AS, Blow MJ, Attanasio C, Akiyama JA, Holt A, Hosseini R, Phouanenavong S, Plajzer-Frick I, Shoukry M, Afzal V, Rubenstein JL, Rubin EM, Pennacchio LA, Visel A.

Cell. 2013 Dec 19;155(7):1521-31. doi: 10.1016/j.cell.2013.11.033.

20.

Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Niciu MJ, Henter ID, Sanacora G, Zarate CA Jr.

World J Biol Psychiatry. 2014 Jan;15(1):2-16. doi: 10.3109/15622975.2013.829585. Review.

Supplemental Content

Support Center